A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study of PBK_L1704 for the Treatment of Moderate to Severe Acute Pain After Bunionectomy in South Korea
Latest Information Update: 26 Aug 2022
At a glance
- Drugs PBK-L-1704 (Primary)
- Indications Postoperative pain
- Focus Registrational; Therapeutic Use
- Sponsors Pharmbio Korea
Most Recent Events
- 26 Aug 2022 New trial record